跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA ALENICUM 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA ALENICUM 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA ALENICUM 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Galenicum Health S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 26, 2023
Approval ID
ba2ded5a8727db16
Company
Galenicum Health S.L.U.
Type
Standard
Approval Details
Approval Id
ba2ded5a8727db16
Drug Cima Aemps Name
SITAGLIPTINA ALENICUM 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88863
Holder Company Name
Galenicum Health S.L.U.
Marketing Company Name
Galenicum Health S.L.U.
Authorization Date
2023-05-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Galenicum Health S.L.U.
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
113,37 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 26, 2023
Approval ID
ba2ded5a8727db16
Type
Standard
Back to CIMA-AEMPS Approvals